Home   Contact Palatin   Site Map  

Press Releases

 
2002 2003 2004 2005 all
 
 

 
Displaying releases: 1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-105 | 106-120 | 121-135 | 136-150 | 151-165 | 166-180 | 181-195 | 196-203


  Apr-28-2003 Positive Phase 2A Data for Palatin’s PT-141 Presented at the American Urological Association Meeting
  Apr-24-2003 Palatin Technologies, Inc. Reports Positive LeuTech® Data in Diabetic Patients with Suspected Pedal Osteomyelitis
  Apr-08-2003 Errol DeSouza, Ph.D. Joins Palatin Technologies, Inc. Board of Directors
  Apr-03-2003 Palatin Technologies, Inc. to be Granted Key US Patent for PT-141 Novel Treatment for Male and Female Sexual Dysfunction
  Mar-31-2003 Palatin Technologies, Inc. Raises $19 Million to Further Advance Product Development
  Mar-03-2003 Palatin Technologies Announces Teleconference and Webcast to be Held on Wednesday, March 5, 2003
  Feb-18-2003 Palatin Technologies Reports Second Quarter Results
  Jan-22-2003 Palatin Technologies Reports Positive PT-141 Data in Patients with an Inadequate Response to Viagra®
  Nov-20-2002 Palatin Technologies, Inc. Raises $11.5 Million
  Nov-15-2002 Palatin Technologies Reports First Quarter Results
  Nov-01-2002 Palatin Technologies’ to present at the CIBC Healthcare Conference
  Oct-14-2002 Palatin Technologies’ PT-141 Selectively Increases Female Sexual Behavior in Preclinical Studies
  Oct-01-2002 Palatin Technologies Reports Fourth Quarter, Year End 2002 Results
  Sep-26-2002 Palatin Technologies Reports Phase 1 Data for PT-141
  Sep-24-2002 Complete Phase 2A Data Presented for PT-141